⌘K
t
ECO Animal Health Group plc announced on 25 September 2025 that all 13 resolutions proposed at its Annual General Meeting were duly passed. Votes "For" resolutions ranged from 82.091% to 99.900%, with "Against" votes ranging from 0.100% to 17.909% for the respective resolutions.
| Date | 25 Sept 2025 |
| Time | 15:15:00 |
| Category | AGMs and other meetings |
| ID | 8757A |
25 September 2025
ECO Animal Health Group plc
("ECO" or the "Company")
Result of Annual General Meeting
ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that at its Annual General Meeting held today all resolutions proposed to the meeting were duly passed.
Votes received in relation to each resolution were as follows:
|
Resolution |
For |
% |
Discretionary |
% |
Against |
% |
|
01 |
35,042,909 |
99.900 |
Nil |
0.00 |
34,924 |
0.100 |
|
02 |
34,840,996 |
99.330 |
Nil |
0.00 |
234,879 |
0.670 |
|
03 |
28,794,146 |
82.091 |
Nil |
0.00 |
6,281,729 |
17.909 |
|
04 |
28,807,698 |
82.126 |
Nil |
0.00 |
6,269,884 |
17.874 |
|
05 |
34,854,006 |
99.363 |
Nil |
0.00 |
223,576 |
0.637 |
|
06 |
34,828,949 |
99.291 |
Nil |
0.00 |
248,633 |
0.709 |
|
07 |
34,854,513 |
99.364 |
Nil |
0.00 |
223,069 |
0.636 |
|
08 |
34,854,513 |
99.364 |
Nil |
0.00 |
223,069 |
0.636 |
|
09 |
35,026,916 |
99.860 |
Nil |
0.00 |
48,959 |
0.140 |
|
10 |
35,029,648 |
99.869 |
Nil |
0.00 |
45,976 |
0.131 |
|
11 |
35,024,511 |
99.854 |
Nil |
0.00 |
51,364 |
0.146 |
|
12 |
35,014,864 |
99.826 |
Nil |
0.00 |
61,011 |
0.174 |
|
13 |
35,014,269 |
99.824 |
Nil |
0.00 |
61,606 |
0.176 |
-Ends-
Contacts
|
|
About ECO Animal Health
ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.
Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.
Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.
Click here for more information: https://ecoanimalhealth.com